We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+16.68%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$88.8B
AUM Growth
+$10B
(+13%)
Cap. Flow
+$220M
Cap. Flow
% of AUM
0.25%
Top 10 Holdings %
Top 10 Hldgs %
31.47%
Holding
3,325
New
753
Increased
947
Reduced
893
Closed
691
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRCL
Circle Internet Group
CRCL
|
+$1.39B |
| 2 |
NVIDIA
NVDA
|
+$910M |
| 3 |
Amazon
AMZN
|
+$440M |
| 4 |
T-Mobile US
TMUS
|
+$432M |
| 5 |
Eli Lilly
LLY
|
+$398M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.3B |
| 2 |
Tesla
TSLA
|
+$880M |
| 3 |
Danaher
DHR
|
+$535M |
| 4 |
Intuit
INTU
|
+$467M |
| 5 |
Visa
V
|
+$437M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.88% |
| 2 | Consumer Discretionary | 13.54% |
| 3 | Healthcare | 10.42% |
| 4 | Financials | 8.78% |
| 5 | Communication Services | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
Eledon Pharmaceuticals
ELDN
$284M
| $257K | ﹤0.01% |
94,772
+75,572
| +394% | +$227K |
|
2352
US Foods
USFD
$23.9B
| $253K | ﹤0.01% |
3,287
-1,813
| -36% | -$129K |
|
2353
Pembina Pipeline
PBA
$27.8B
| $253K | ﹤0.01% |
+6,736
| New | +$254K |
|
2354
Bruker
BRKR
$8.58B
| $252K | ﹤0.01% |
+6,112
| New | +$236K |
|
2355
Puma Biotechnology
PBYI
$442M
| $252K | ﹤0.01% |
73,415
-142,998
| -66% | -$456K |
|
2356
Expedia Group
EXPE
$37.7B
| $251K | ﹤0.01% |
1,487
-256,421
| -99% | -$41.6M |
|
2357
Codexis
CDXS
$161M
| $250K | ﹤0.01% |
+102,378
| New | +$240K |
|
2358
ASP Isotopes
ASPI
$540M
| $250K | ﹤0.01% |
33,937
-144,197
| -81% | -$967K |
|
2359
Afya
AFYA
$1.23B
| $249K | ﹤0.01% |
+13,926
| New | +$255K |
|
2360
Vanguard Consumer Discretionary ETF
VCR
$6.16B
| $248K | ﹤0.01% |
+685
| New | +$232K |
|
2361
CALL
ExxonMobil
XOM
$662B
| $248K | ﹤0.01% |
+2,300
| New | +$246K |
|
2362
BorgWarner
BWA
$14.1B
| $247K | ﹤0.01% |
+7,377
| New | +$226K |
|
2363
Oaktree Specialty Lending
OCSL
$1.12B
| $246K | ﹤0.01% |
+18,011
| New | +$254K |
|
2364
Global X Cloud Computing ETF
CLOU
$271M
| $245K | ﹤0.01% |
+10,501
| New | +$230K |
|
2365
SoundThinking
SSTI
$105M
| $245K | ﹤0.01% |
+18,754
| New | +$292K |
|
2366
Principal Exchange-Traded Funds Principal US Mega-Cap ETF
USMC
$3.69B
| $245K | ﹤0.01% |
+3,912
| New | +$228K |
|
2367
Kura Oncology
KURA
$874M
| $244K | ﹤0.01% |
42,363
-349,686
| -89% | -$2.14M |
|
2368
Roundhill Ball Metaverse ETF
METV
$212M
| $244K | ﹤0.01% |
+14,325
| New | +$212K |
|
2369
Chefs' Warehouse
CHEF
$4.44B
| $243K | ﹤0.01% |
+3,811
| New | +$226K |
|
2370
Dave & Buster's
PLAY
$343M
| $243K | ﹤0.01% |
+8,066
| New | +$182K |
|
2371
Jakks Pacific
JAKK
$291M
| $242K | ﹤0.01% |
11,663
-129,525
| -92% | -$2.64M |
|
2372
Avery Dennison
AVY
$13.5B
| $241K | ﹤0.01% |
+1,374
| New | +$241K |
|
2373
Anika Therapeutics
ANIK
$277M
| $241K | ﹤0.01% |
+22,782
| New | +$287K |
|
2374
DiaMedica Therapeutics
DMAC
$358M
| $241K | ﹤0.01% |
61,719
+42,890
| +228% | +$167K |
|
|
MAZE
2375
Maze Therapeutics
MAZE
$1.51B
| $240K | ﹤0.01% |
19,597
| – | – |
|
Similar funds
Marshall Wace's Q2 2025 Portfolio in Review
As of Q2 2025, Marshall Wace held 3,325 positions worth $88.8B, up 13% from $78.8B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Marshall Wace's Q2 2025 filing shows 753 new, 947 increased, 893 reduced and 691 closed positions. Its largest new stake was Circle Internet Group: 8,534,470 shares worth $1.55B. The largest sale was iShares Core S&P 500 ETF, an estimated $1.3B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Marshall Wace's largest Q2 2025 buy was Circle Internet Group: 8,534,470 shares worth $1.55B.
- Marshall Wace added most to NVIDIA in Q2 2025, an estimated $910M increase.
- Marshall Wace's biggest Q2 2025 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.3B.
- Marshall Wace fully exited Cboe Global Markets in Q2 2025, selling an estimated $191M.
- Marshall Wace's ten largest holdings make up 31% of its $88.8B portfolio in Q2 2025.
- Marshall Wace opened 753 new positions and closed 691 in Q2 2025.
- Marshall Wace's portfolio value rose 13% quarter-over-quarter to $88.8B.
Based on Marshall Wace's 13F filing for Q2 2025, filed 13 Aug 2025.